Feedback / Questions
Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo
https://www.neurology-jp.org/neuro2026/en/program/pdf/e_14.pdf
Akihiro Fujii
May 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next